ESR1 and breast cancer: Accordingly, the silencing of IRS-1 enhanced the tamoxifen-induced cell death in BC cells (Cesarone et al., 2006) and abrogated the transcriptional activity of ER dependent by IGF-1 (Sisci et al., 2007).